<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05073523</url>
  </required_header>
  <id_info>
    <org_study_id>ChalmersUT</org_study_id>
    <nct_id>NCT05073523</nct_id>
  </id_info>
  <brief_title>Dietary Biomarkers 2.0: From Potential Towards Implementation.</brief_title>
  <official_title>Dietary Biomarkers 2.0: From Potential Towards Implementation. A Randomized Controlled Trial to Assess Dose-response Relationships for Dietary Biomarkers of Selected Foods</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chalmers University of Technology</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chalmers University of Technology</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this project is to fill a gap in the translation of dietary biomarkers as unbiased&#xD;
      measures of food intake from high-end academic research into a methodology that ca be easily&#xD;
      applied across academic, public and private health sector to objectively assess specific&#xD;
      dietary intakes at group and individuals' level to a) improve understanding of diet and&#xD;
      health relationships b) address compliance in dietary intervention studies and c) assess&#xD;
      individuals' dietary intakes to guide their eating towards improved health. The study will be&#xD;
      carried out as a three-way cross-over design with three different meal compositions (A, B, C)&#xD;
      where each meal is provided 3 times per day during four days per meal. A wash-out period of 7&#xD;
      days where participants consume their habitual diet is implemented and a 3-day run-in before&#xD;
      the study meal intervention. The first day of study meal intervention includes postprandial&#xD;
      measurements during 8 hours.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 27, 2021</start_date>
  <completion_date type="Anticipated">May 2022</completion_date>
  <primary_completion_date type="Anticipated">May 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Plasma concentrations of dietary candidate biomarkers (daidzein, genistein, hesperetin, naringenin, phloretin, kaempferol, 2-thiothiazolidine-4-carboxylic acid, sulforaphane)</measure>
    <time_frame>24 hours</time_frame>
    <description>Difference in the plasma concentrations of diet specific biomarkers comparing before (baseline) and after intervention meal (average plasma concentration over the 24h period).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Plasma concentrations of dietary biomarker candidates (proline betaine, 4-hydroxyphenylacetic acid, 4-hydroxyphenylpyruvate, indole-3-lactic acid, pipecolic acid, s-methylcysteine, avenacoside-A and avenacoside-B)</measure>
    <time_frame>24 hours</time_frame>
    <description>Difference in the plasma concentrations of diet specific biomarkers comparing before (baseline) and after intervention meal (average plasma concentration over the 24 h period).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Plasma concentration-time profile over 24h (AUCs) of dietary biomarker candidates ( daidzein, genistein, hesperetin, naringenin, phloretin, kaempferol, 2-thiothiazolidine-4-carboxylic acid, sulforaphane)</measure>
    <time_frame>24 hours</time_frame>
    <description>Differences in plasma AUCs between the three intake levels for each biomarker candidate</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Plasma concentration-time profile over 24h (AUCs) of dietary biomarker candidates proline betaine, 4-hydroxyphenylacetic acid, 4-hydroxyphenylpyruvate, indole-3-lactic acid, pipecolic acid, s-methylcysteine, avenacoside-A and avenacoside-B</measure>
    <time_frame>24 hours</time_frame>
    <description>Differences in plasma AUCs between the three intake levels.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Gut microbiome</measure>
    <time_frame>4 days</time_frame>
    <description>Fecal samples will analyzed for composition of the gut microbiome, baseline compared with after 4 days of intervention meals.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Plasma metabolites</measure>
    <time_frame>4 days</time_frame>
    <description>Untargeted metabolomics will be performed using established methods for plasma. Analyzed exploratorily using untargeted metabolomics to find potential biomarker panels that reflect the specific foods included in study meals. Baseline compared with after intervention meals.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Urine metabolites</measure>
    <time_frame>24 hours</time_frame>
    <description>Analyzed exploratorily using untargeted metabolomics to find potential biomarker panels that reflect the specific foods included in study meals.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fecal concentrations of diet specific biomarkers daidzein, genistein, hesperetin, naringenin, phloretin, kaempferol, 2-thiothiazolidine-4-carboxylic acid, sulforaphane</measure>
    <time_frame>4 days</time_frame>
    <description>Evaluate new simple sampling techniques using faecal swabs.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fecal concentrations of diet specific biomarkers proline betaine, 4-hydroxyphenylacetic acid, 4-hydroxyphenylpyruvate, indole-3-lactic acid, pipecolic acid, s-methylcysteine, avenacoside-A and avenacoside-B)</measure>
    <time_frame>4 days</time_frame>
    <description>Evaluate new simple sampling techniques using fecal swabs.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood concentrations of diet specific biomarkers daidzein, genistein, hesperetin, naringenin, phloretin, kaempferol, 2-thiothiazolidine-4-carboxylic acid, sulforaphane</measure>
    <time_frame>4 days</time_frame>
    <description>Evaluate new simple sampling techniques using dried blood spots.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood concentrations of diet specific biomarkers proline betaine, 4-hydroxyphenylacetic acid, 4-hydroxyphenylpyruvate, indole-3-lactic acid, pipecolic acid, s-methylcysteine, avenacoside-A and avenacoside-B)</measure>
    <time_frame>4 days</time_frame>
    <description>Evaluate new simple sampling techniques using dried blood spots.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Urine concentrations of diet specific biomarkers daidzein, genistein, hesperetin, naringenin, phloretin, kaempferol, 2-thiothiazolidine-4-carboxylic acid, sulforaphane</measure>
    <time_frame>4 days</time_frame>
    <description>Evaluate new simple sampling techniques using dried urine spots.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood concentrations of diet specific biomarkers proline betaine, 4-hydroxyphenylacetic acid, 4-hydroxyphenylpyruvate, indole-3-lactic acid, pipecolic acid, s-methylcysteine, avenacoside-A and avenacoside-B</measure>
    <time_frame>4 days</time_frame>
    <description>Evaluate new simple sampling techniques using dried urine spots.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">24</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>Meal A</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Diet: meal proportion 1</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Meal B</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Diet: meal proportion 2</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Meal C</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Diet: meal proportion 3</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Diet</intervention_name>
    <description>All intervention meals consist of five different food groups including fruits, vegetables, legumes, dairy products, and whole grains. Differences in the proportion of these foods in Meal A-C is tested.</description>
    <arm_group_label>Meal A</arm_group_label>
    <arm_group_label>Meal B</arm_group_label>
    <arm_group_label>Meal C</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Men and women&#xD;
&#xD;
          -  Age 18-80 years&#xD;
&#xD;
          -  Body mass index (BMI) 18.5-30 kg/m2&#xD;
&#xD;
          -  Fasting glucose ≤ 6.1 mmol/l&#xD;
&#xD;
          -  Low density lipoprotein (LDL), Cholesterol ≤ 5.30 mmol/L&#xD;
&#xD;
          -  Triglycerides ≤ 2.60 mmol/L&#xD;
&#xD;
          -  Signed informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Food allergies or intolerances preventing consumption of any products included in the&#xD;
             study.&#xD;
&#xD;
          -  Strict vegetarian or vegan, participants must be able to eat dairy products as it is&#xD;
             included in the study diet.&#xD;
&#xD;
          -  Unable to sufficiently understand written and spoken Swedish to provide written&#xD;
             consent and understand information and instructions from the study personal.&#xD;
&#xD;
          -  Unable to satisfactorily complete the 3-day weighted food records.&#xD;
&#xD;
          -  Continuous/daily use of medication.&#xD;
&#xD;
          -  Pregnant, lactating or planning a pregnancy during the study period.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rikard Landberg, Dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>Chalmers University of Technology</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Therese Karlsson, Dr</last_name>
    <phone>+46722406265</phone>
    <email>therese.karlsson@chalmers.se</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Gothenburg, Department of Food and Nutrition and Sport Science</name>
      <address>
        <city>Gothenburg</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Therese Karlsson</last_name>
      <phone>+46722406265</phone>
      <email>therese.karlsson@chalmers.se</email>
    </contact>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>September 6, 2021</study_first_submitted>
  <study_first_submitted_qc>September 28, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 11, 2021</study_first_posted>
  <last_update_submitted>September 28, 2021</last_update_submitted>
  <last_update_submitted_qc>September 28, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 11, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Chalmers University of Technology</investigator_affiliation>
    <investigator_full_name>Rikard Landberg</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

